快讯

Wallstreetcn
2025.11.06 13:57

Eli Lilly's U.S. stock pre-market rose nearly 2% at one point, as the company's new weight loss drug achieved over 20% weight reduction and plans to cooperate with the White House to expand Medicare coverage

来源：Wallstreetcn 本文版权归属原作者/机构所有。
当前内容仅代表作者观点，与本平台立场无关。内容仅供投资者参考，亦不构成任何投资建议。如对本平台提供的内容服务有任何疑问或建议，请联系我们。